BDX vs. COO, HOLX, HSIC, AMN, CAH, DVA, MCK, TMO, ISRG, and BSX
Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Cooper Companies (COO), Hologic (HOLX), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), McKesson (MCK), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
Becton, Dickinson and Company vs. Its Competitors
Becton, Dickinson and Company (NYSE:BDX) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.
Becton, Dickinson and Company has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Cooper Companies has a net margin of 10.39% compared to Becton, Dickinson and Company's net margin of 7.28%. Becton, Dickinson and Company's return on equity of 15.99% beat Cooper Companies' return on equity.
Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 2.0% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Becton, Dickinson and Company currently has a consensus target price of $219.22, suggesting a potential upside of 22.94%. Cooper Companies has a consensus target price of $97.20, suggesting a potential upside of 33.80%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.
In the previous week, Becton, Dickinson and Company had 11 more articles in the media than Cooper Companies. MarketBeat recorded 30 mentions for Becton, Dickinson and Company and 19 mentions for Cooper Companies. Becton, Dickinson and Company's average media sentiment score of 0.86 beat Cooper Companies' score of 0.85 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.
Summary
Becton, Dickinson and Company and Cooper Companies tied by winning 8 of the 16 factors compared between the two stocks.
Get Becton, Dickinson and Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Becton, Dickinson and Company Competitors List
Related Companies and Tools
This page (NYSE:BDX) was last updated on 7/17/2025 by MarketBeat.com Staff